AS

Atluri Sreevarun

Active Director Director DIN 01588934
DIN 01588934 First appointment Nov 2007 Primary industry Consumer Electronics & Durables
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 6 historical roles
Total affiliations 8 Since Nov 2007
Shareholding value •••• Premium profile

About Atluri Sreevarun

Data last updated:

Atluri Sreevarun is a Director at Hightronics Enterprises Private Limited (since 2012) and Director at Amrak Pharma Private Limited (since 2021). The companies operate in Consumer Electronics & Durables, Pharma and Infrastructure and Utilities. The largest current company by reported revenue is Hightronics Enterprises Private Limited at ₹1.36 Cr (FY 2021). Earlier, Atluri Sreevarun was a Director at Atluri Developers Private Limited (2007–2023) and Director at Atluri Technologies Private Limited (2010–2016) and 4 more.

DIN 01588934
Primary Designation Director
Industry Consumer Electronics & Durables
First Appointment 12 Nov 2007
Oldest Company Age 16 yrs
Largest company Hightronics Enterprises Private Limited · ₹1.36 Cr (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jun 20122012₹1.36 Cr (FY 2021)Active
Amrak Pharma Private Limited U24303TG2021PTC157867
Director13 Dec 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Atluri Developers Private Limited U70100TG2007PTC056273
Director12 Nov 20072007₹14.76 Cr (FY 2025)Active
Atluri Technologies Private Limited U72900TG2010PTC067802
Director05 Apr 20102010₹8.8 Lakh (FY 2025)Active
Atdec Mounts (India) Private Limited U51909TG2010PTC068937
Director14 Jun 20102010Strike Off
Atluri Energy Private Limited U40102TG2010PTC068973
Director16 Jun 20102010Strike Off
Studeria Placements Private Limited U74910TG2009PTC066465
Director23 Dec 20092009Strike Off
Director09 Dec 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Amrak Pharma Private Limited
Atluri Energy Private Limited
Studeria Placements Private Limited
Hightronics Enterprises Private Limited
Premium access

Shareholding and investment profile for Atluri Sreevarun

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atluri Sreevarun

Atluri Sreevarun currently holds 2 directorships: Hightronics Enterprises Private Limited (Director, since 06 Jun 2012, revenue ₹1.36 Cr (FY 2021)); Amrak Pharma Private Limited (Director, since 13 Dec 2021).

Atluri Sreevarun was first appointed on 12 Nov 2007 as Director at Atluri Developers Private Limited. The most recent appointment on record is 13 Dec 2021 at Amrak Pharma Private Limited.

Atluri Sreevarun held 6 earlier board appointments: Atluri Developers Private Limited (Director, 12 Nov 2007 to 04 Feb 2023); Atluri Technologies Private Limited (Director, 05 Apr 2010 to 07 Mar 2016); Atdec Mounts (India) Private Limited (Director, 14 Jun 2010 to 07 Mar 2016); Atluri Energy Private Limited (Director, from 16 Jun 2010); Studeria Placements Private Limited (Director, from 23 Dec 2009); and 1 more.

The current boards of Atluri Sreevarun's companies include Lavanya Atluri (Hightronics Enterprises Private Limited), Makkapati Prudeesh Chakravarthi (Amrak Pharma Private Limited), Makkapati Soujanya (Amrak Pharma Private Limited), Samba Siva Rao Peddi (Amrak Pharma Private Limited), Swathi Ramaraju (Amrak Pharma Private Limited), Venkata Reddy Arumalla (Amrak Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available